Skip to content

Comparison of combined misoprostol and oxytocin with oxytocin alone in the control of blood loss during elective caesarean section.

Comparison of combined misoprostol and oxytocin with oxytocin alone in the control of blood loss during elective caesarean section.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202310568262804
Enrollment
174
Registered
2023-10-12
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery

Interventions

Combined misoprostol and oxytocin
Oxytocin plus placebo

Sponsors

Federal Government of Nigeria
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Consenting women with term pregnancies undergoing elective lower segment caesarean delivery under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: Women with predisposing factors for PPH, such as; Multiple gestations, Placenta praevia, Undiagnosed vaginal bleeding, were excluded from the study. Patients who had general anaesthesia Patients with surgical indications requiring general anaesthesia, cardiovascular, renal, or hepatic dysfunction. Patients who presented with fever or refused to give consent were excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure was blood loss (intra-operative and postpartum within 24 hours of delivery) estimated in millilitres.

Secondary

MeasureTime frame
The secondary outcome measures included; a significant change in pre- and post-delivery haematocrit, the need for additional uterotonic interventions in the 24 hours following delivery to maintain proper uterine tone, the need for blood transfusion, and medication side effects such as fever, headache, shivering, nausea, vomiting, and hypotension.

Countries

Nigeria

Contacts

Public ContactOlubunmi Tunde Olatunji

Medical Consultant

olubunmiolatunji@gmail.com+2348035863359

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026